New York, Global Insight Services have recently published a report on Huntington’s Disease – Drug Pipeline Landscape, 2022. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Huntington’s disease is a progressive brain disorder caused by a single defective gene on chromosome 4. This gene produces a protein called huntingtin, which is essential for normal brain development. However, when the gene is defective, it produces an abnormal form of huntingtin that is toxic to brain cells. The damage caused by the abnormal protein gradually destroys certain nerve cells in the brain, which leads to the characteristic symptoms of Huntington’s disease.
The exact cause of the genetic defect that leads to Huntington’s disease is unknown. However, it is thought to be due to a combination of environmental and genetic factors. Huntington’s disease is usually diagnosed in adults between the ages of 30 and 50, but it can also occur in children and adolescents. The disease is usually fatal within 15 to 20 years of onset.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31029
Report Highlights
Global Insight Service’s, Huntington’s Disease – Drug Pipeline Landscape, 2022 report provides an overview of the Huntington disease pipeline drugs. This report covers detailed insights on Huntington’s Disease drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Huntington’s Disease pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Some of the key players involved in development of Huntington’s Disease therapeutics are :
Key Players
• AFFiRiS AG
• Alchemab Therapeutics Ltd
• Alsonex Pty Ltd
• Anima Biotech Inc
• Annexon, Inc.
• Annji Pharmaceutical Co Ltd
• Aop Orphan Pharmaceuticals AG
• Arvinas Inc
• Asdera LLC
• Asklepios BioPharmaceutical Inc
• Atalanta Therapeutics Inc
• Azevan Pharmaceuticals
• Berg LLC
• Bionaut Labs Inc
• BrainStorm Cell Therapeutics Inc
• Cellavita Pesquisa CientÃfica Ltda
• Celon Pharma
• Ceptur Therapeutics Inc
• Chaperone Therapeutics Inc
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31029
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700